The BTB/POZ transcriptional repressor HIC1 (Hypermethylated in Cancer 1) is a tumor suppressor gene located at chromosome 17p13.3, a region frequently hypermethylated or deleted in human tumors and in a contiguous-gene syndrome, the Miller-Dieker syndrome. The human and murine HIC1 genes are composed of two alternative 5 0 exons, 1a and 1b fused to a large second coding exon 2. Exon 1a is a noncoding exon associated with a major G-C-rich promoter whereas exon 1b is a downstream coding exon associated with a minor TATA box promoter. By human-mouse genome comparison, we have identified a short upstream conserved sequence containing G-C boxes which were shown to be functional. Transcripts initiating from this new promoter were detected in various human and mouse tissues and contained a long 5 0 -UTR sequence, called 1c which encompass the G-C-rich promoter associated with exon 1a and uses the same splice donor site. RT-PCR analyses of two primary breast epithelial cell lines identified two other 5 0 -UTRs generated by alternative splicing within exon 1c. Our results thus highlight the existence of an unexpected complex transcriptional regulation of HIC1.
The BTB/POZ transcriptional repressor HIC1 (Hypermethylated in Cancer 1) is a tumor suppressor gene located at chromosome 17p13.3, a region frequently hypermethylated or deleted in human tumors and in a contiguous-gene syndrome, the Miller-Dieker syndrome. The human and murine HIC1 genes are composed of two alternative 5 0 exons, 1a and 1b fused to a large second coding exon 2. Exon 1a is a noncoding exon associated with a major G-C-rich promoter whereas exon 1b is a downstream coding exon associated with a minor TATA box promoter. By human-mouse genome comparison, we have identified a short upstream conserved sequence containing G-C boxes which were shown to be functional. Transcripts initiating from this new promoter were detected in various human and mouse tissues and contained a long 5 0 -UTR sequence, called 1c which encompass the G-C-rich promoter associated with exon 1a and uses the same splice donor site. RT-PCR analyses of two primary breast epithelial cell lines identified two other 5 0 -UTRs generated by alternative splicing within exon 1c. Our results thus highlight the existence of an unexpected complex transcriptional regulation of HIC1.
Introduction
Loss of heterozygosity (LOH) on the short arm of chromosome 17 (17p) is one of the most common genetic alterations in human cancers. Allelic losses most often coincide with mutations in the TP53 gene at 17p13.1 (Ko and Prives, 1996) . There has been mounting evidence, however, that one or more tumor suppressor genes could be located in a region telomeric to TP53 (Liscia et al., 1999) . Indeed, the microsatellite marker D17S5 in 17p13.3 has shown frequent LOH or alteration in DNA methylation (Baylin et al., , 2001 in various common types of solid tumors (Fujii et al., 1998; Kanai et al., 1999; Rood et al., 2002) and in some leukemia (Melki et al., 1999) . DNA hypermethylation changes at the D17S5 locus in many cancers allowed the positional cloning of HIC1 (Hypermethylated In Cancer 1) that encodes a transcriptional repressor with five Kru¨ppel-like C 2 H 2 zinc-finger motifs and a N-terminal BTB/POZ domain (Makos-Wales et al., 1995; Deltour et al., 1999) . Clues to the tumor suppressor function of HIC1 have come from the study of heterozygous HIC1 þ /À mice which develop, after 70 weeks, many different spontaneous malignant tumors .
Several other putative candidate tumor suppressor genes have been localized in 17p13.3, in the vicinity of the D17S5 marker. In particular, OVCA1/DPH2L1 and OVCA2 have been located in an approximately 15.0 kbp minimum region of allelic loss extending from markers D17S28 to D17S5 which is deleted in 80% of all ovarian epithelial malignancies (Philips et al., 1996; Schultz et al., 1996; Bruening et al., 1999) . Even though it is not included in this minimal region of deletion, HIC1 still remains a strong candidate since critical 5 0 regulatory elements reside in the close vicinity of the D17S28-D17S5 interval. Previously, we described a major alternative G-C-rich promoter of the HIC1 gene located approximately 1.0 kbp downstream of the D17S5 marker (Gue´rardel et al., 2001) . The exon-intron structures of the human and murine HIC1 genes appeared very similar since they are both composed of two alternative first exons followed by a large second coding exon, exon 2, which also contains the 3 0 untranslated region (Figure 1 ). Exon 1a is noncoding and associated with the major G-C-rich promoter whereas exon 1b is coding and associated with a TATA promoter (Carter et al., 2000; Gue´rardel et al., 2001) . Both types of transcripts are detected in various normal tissues with a predominance for exon 1a transcripts and are upregulated by p53 (Makos-Wales et al., 1995; Gue´rardel et al., 2001 ).
In addition to tumorigenesis, the chromosomal 17p13.3 region has also been implicated in a contiguous-gene syndrome caused by heterozygous gene deletions, the Miller-Dieker syndrome (MDS), a severe form of lissencephaly accompanied by developmental anomalies. Whereas the isolated lissencephaly sequence (ILS) is due to point mutations or intragenic deletions in the LIS1 gene, the more severe cortical phenotype seen in MDS as well as the cranio-facial and limbs defects are due to heterozygous deletions in another critical region in 17p13.3 including HIC1 (Yingling et al., 2003) . The deletion of HIC1 could be involved in some developmental defects associated with MDS since, together with perinatal death and a reduction in overall size, Hic1À/À mouse embryos have cranio-facial and limb defects resembling those found in MDS patients (Carter et al., 2000) .
In this study, we have identified a short phylogenetically conserved region located 420 bp downstream of the D17S5 marker and containing putative consensus sequences for transcription initiation signals, namely G-C boxes. Functional assays clearly demonstrate the presence of a novel alternative promoter conserved in the murine and human HIC1 genes. Transcripts initiating from this promoter called P2 contain a new 5 0 -UTR called 1c and can be detected only by RT-PCR analyses of polyA þ RNAs prepared from normal mouse ovaries and from normal human ovaries and mammary glands. In addition, we have also identified new splicing sites in exon 1c which are functional in some human mammary epithelial cell lines and give rise to two other types of 5 0 -UTR. Thus, the human HIC1 gene is subject to an unexpected complex regulation both at the level of transcriptional initiation and splicing mechanisms.
Results
In silico identification of a putative transcription initiation site in a conserved region upstream of exon 1a in the human, murine and rat HIC1 genes We and others have described similar genomic organization of HIC1, respectively, in human (Gue´rardel et al., 2001 ) and in mice (Carter et al., 2000) albeit with different names for the 5 0 alternative exons. To avoid confusion, we will adopt the nomenclature of Carter et al. (2000) : an upstream exon 1a associated with a G-C-rich promoter, called P1 and a downstream exon 1b driven by a TATA-box promoter, called P0 (Figure 1) .
In addition to a 220 nucleotide homologous region corresponding to the alternative exon 1a and its associated P1 promoter, alignments of the human (Accession N1: AJ404688) and murine (Accession N1: AF036582) HIC1 genomic sequences using the BLAST network services (http://www.ncbi.nlm.nih.gov/BLAST/) also identified a second, albeit shorter, 51 nucleotide region of homology (94% homology, expected value 1e À12 ). This region, located approximately 1.0 kbp upstream of the major transcription start site associated with exon 1a (Figures 1 and 2 ), contained conserved G-C boxes (Figure 1 ). By contrast, the 1.1 kbp murine or 1.0 kbp human sequences separating these two highly homologous regions are not significantly conserved (Figure 1 ). This newly identified putative promoter sequence is located very close to the boundary of the previously published murine sequence (Grimm et al., 1999) . We therefore extended this sequence by nucleotide sequencing of our murine Hic1 genomic clone (Gue´rardel et al., 2001) . Comparison of this new 750 bp genomic sequence (Accession N1: AJ414163) with its Figure 1 Schematic structure of the human and murine HIC1 loci. The two alternative 5 0 exons, 1a (dashed box) and 1b, and the large coding exon, 2, containing the BTB/POZ and zinc-fingers (ZF) domains are shown. The open reading frame in exon 1b is shown as a gray box. The major G-C-rich promoter (P1) associated with exon 1a and the minor TATA-box promoter (P0) associated with exon 1b are shown as a bent arrow. The black boxes refer to the upstream region of strong homology found between the murine and the human sequences and containing G-C-rich sequences. Numbering is as in AJ404688 (Human) and AF036582 (Murine)
A second G-C-rich promoter in the HIC1 gene S Pinte et al Figure 2 Characterization of a second conserved region in the mammalian HIC1 genomic sequences. (a) 5 0 genomic sequences of the human and murine HIC1 genes. The 5 0 part of the human HIC1 locus is shown as a 2531 bp composite genomic fragment corresponding to the human variable-number tandem repeat maternal allele 6A of the marker locus D17S5 sequence (900 bp, Accession N1: M21143) fused to the sequence of the adjacent 1631 bp genomic fragment (Accession N1: AJ404688) containing the HIC1 exon 1a. Similarly, the 5 0 part of the murine Hic1 locus is shown as a 2090 bp composite genomic fragment corresponding to the new genomic sequence (750 bp, Accession N1: AJ414163) and the adjacent region in the murine sequence (Accession N1: AF036582). The second region of homology located upstream of the putative G-C boxes (black box) is shown as checked boxes and the percentages of homology obtained with BLAST program (defaults parameters) are indicated. (b) Multiple alignments of the mammalian HIC1 genomic sequences. Homologous sequences starting at the 5 0 BamHI site in the human AJ404688 sequence were aligned with CLUSTAL/Jalview (EMBL) and defaults parameters. The output file was subsequently edited manually. The murine sequence is the composite sequence described above. The rat sequence is derived from the draft version of the rat genome (Accession N1: NW_047336.1). Numbering is indicated only for the human sequence (AJ404688). The homologous regions obtained with the BLAST program and the conserved G-C boxes are highlighted, respectively, with gray and black boxes. The conserved AP-1 and Sp1 consensus binding sites are indicated in bold and underlined. A BamHI and a KpnI restriction sites used for some human promoter constructs are underlined. s.d: splice donor site A second G-C-rich promoter in the HIC1 gene S Pinte et al human homologue using the BLAST program highlighted a second region of high homology (78%) located just upstream of the conserved G-C boxes (Figure 2a ). Furthermore, a highly homologous sequence was found by comparisons with the murine sequence and the rat genome (Accession N1: NW_047336.1). When the three sequences were aligned using the CLUSTAL program (http://www.ebi.ac.uk./clustalw/), the putative G-C boxes as well as the upstream regulatory sequences appeared highly conserved among these three species (Figure 2b ). In addition, pattern-based computational approaches identified several putative binding sites for activating protein 1 (AP-1) and for stimulating protein 1 (Sp1) which are conserved in the human, mouse and rat sequences. By contrast, no significant homology was detected with the BLAST program (defaults parameters) between the murine sequence and the sequence of the adjacent human BamHI restriction fragment containing the D17S5 microsatellite marker (Figure 2a and data not shown).
Thus, this portion of the human and rodent HIC1 loci share a very similar structural organization with two unrelated regions flanking two highly conserved regions containing G-C boxes. Such a high conservation across species strongly suggests that we have identified a new putative promoter of the HIC1 locus.
Functional analyses of a distal human promoter conserved in the rodent HIC1 genes To determine whether this second region of homology in the HIC1 genes functions as a bona fide promoter, its ability to drive reporter gene transcription was studied by transient transfection assays. A BamHI-SacI fragment encompassing these conserved G-C boxes and upstream regulatory sequences but lacking the major G-C-rich P1 promoter associated with exon 1a (Figure 3 ) was cloned in the sense orientation directly upstream of the luciferase reporter gene in the promoterless pGL3-Basic vector (Promega). This construct, pGL3-BSa, was transiently transfected in RK13 cells, as previously described (Gue´rardel et al., 2001) . As shown in Figure 3 , the mean reporter activity obtained with this BamHI-SacI fragment, containing the 0 sequences subcloned upstream of the luciferase gene in the reporter plasmid, pGL3-Basic. The relevant restriction sites used to construct the various deletions are indicated. The localization of the HIC1 1a exon in the 1.58 kbp BamHI fragment is schematically drawn as well as the conserved G-C boxes. The bent arrow indicates the major transcription initiation site, called P1, previously identified in front of the 1a exon (Gue´rardel et al., 2001) . Reporter constructs were transfected in triplicate in RK13 cells, harvested and assayed for luciferase activity. The normalized luciferase activity is shown in the right panel (black boxes). Data shown represent the average of three independent experiments with standard deviations. (b) Schematic drawing of the two G-C-rich promoters. The 1a exon and the conserved G-C boxes are shown, respectively, as a dashed box and as a black box. The two conserved G-C-rich promoters, P1 (Gue´rardel et al., 2001 ) and P2 (this study) are shown as bent arrows. The two regions of homology found between the human and murine loci are shown as arrows. sd: splice donor site A second G-C-rich promoter in the HIC1 gene S Pinte et al homologous upstream region, was more than 50-fold greater than the promoter-less pGL3-Basic control vector. The pGL3-BB construct, containing the 1.58 kbp BamHI fragment also containing the major P1 promoter and used as a positive control, produced a similar 45-fold increase in luciferase expression above the control. These data clearly demonstrate that a region within this BamHI-SacI fragment is capable of directing transcription. To better define this HIC1 upstream promoter, we created two additional 3 0 and 5 0 nested deletions. Conspicuous luciferase activity was obtained with the pGL3-BSc (3 0 deletion) and pGL3-KSc (5 0 and 3 0 deletions) mutants containing the conserved G-C boxes (Figure 3) . By contrast, their absence in the pGL3-BK (upstream region) and pGL3-ScSa (downstream region) constructs drops the activity to background levels (Figure 3) . Notably, deletion of the upstream genomic sequences located between the BamHI and KpnI restriction sites had only minimal effects on promoter activity (Figure 3 , compare pGL3-KSc with pGL3-BSc).
Collectively, these data clearly demonstrate that the conserved upstream region is a second G-C-rich promoter of the HIC1 gene, thus called P2 and that the 0.34 kbp KpnI-ScaI fragment is a minimal promoter region containing the essential cis-acting elements necessary for the basal transcription.
Characterization of an additional alternative exon of the human and murine HIC1 genes Since several attempts to detect by Northern blot transcripts derived from this new P2 promoter were unsuccessful (data not shown), we used more sensitive techniques, such as RT-PCR. Starting with cDNAs prepared from highly purified polyA þ RNAs obtained from a pool of normal human mammary glands or ovaries (Marathon Ready cDNAs, Clontech), we performed PCR analyses with primers designated to be unique for sequences located just downstream of the newly characterized G-C boxes and in the BTB/POZ domain (Table 1 ). Electrophoresis analyses of the primary PCR products showed in both cases an unique DNA fragment of the expected size (1042 bp) (Figure 4 , lanes 2 and 8) which was cloned and sequenced. These results demonstrated that this 1042 bp fragment (Accession N1: AJ550616) originated from a splicing event using the previously described canonical splice donor and splice acceptor sites in exons 1a and 2 (Table 2) (Gue´rardel et al., 2001) . Thus, we have identified in normal human tissues a new type of HIC1 transcript derived from the upstream G-C-rich P2 promoter and containing a new 5 0 -untranslated region (5 0 -UTR) named 1c, fused by splicing to the coding exon 2. Notably, this rather long 5 0 -UTR contains not only the exon 1a but also the major P1 promoter sequences.
We have also analysed two primary cultures of epithelial cells derived from mammary glands (BREPI 27 and 73). After two rounds of PCR with the same 1c-specific primers, we observed, in addition to the expected 1042 bp product, a band of smaller size which was different in each BREPI cell line (Figure 4) . After cloning and sequencing, these bands were shown to correspond to a double internal splicing event in the 1c exon, yielding two other 5 0 -UTR sequences called 1d and 1e (Accession N1: AJ583693 and AJ583694). Thus, additional functional splice donor and acceptor sites are located in this region (Table 2 and Figure 5 ).
In conclusion, five HIC1 transcripts with different 5 0 ends are produced through a combination of differential promoter usage and alternative splicing mechanisms.
1c transcripts are also detected in murine ovaries
Given that the G-C-rich P2 promoter appears to be conserved in other mammalian species (Figure 2) , we attempt to address whether transcripts derived from this promoter can also be detected in mice. To that end, we performed similar PCR experiments on size-selected fractions of cDNAs transcribed from polyA þ RNAs obtained from normal ovaries of adult mice. After two rounds of PCR with specific nested primers (see Table 1 ), the predicted 1433 bp fragment corresponding to the splicing of sequences downstream of the P2 promoter to the coding exon 2 using the same splice donor site as the murine 1a exon (see Table 2 ) was obtained as shown by its nucleotide sequencing (Accession N1: AJ585343). Positions numbers are as in the human HIC1 genomic sequence (L41919).
c Positions numbers are as in the murine Hic1 genomic sequence (AF036582)
A second G-C-rich promoter in the HIC1 gene S Pinte et al Thus, despite their low abundance, transcripts initiated from the P2 promoter are evolutionarily conserved which strongly argues in favor of their biological importance.
Discussion
A detailed characterization of the HIC1 locus and functional analyses of its 5 0 regulatory regions are still ongoing challenges in order to decipher the molecular mechanisms that control the expression of various HIC1 transcripts in normal tissues. Ultimately, these studies would provide a conceptual framework to understand how the deregulation of HIC1 expression either by genetic (LOH) or epigenetic (aberrant methylation) alterations could lead to tumorigenesis and developmental defects.
In this paper, we describe the characterization of a third functional G-C-rich promoter of the human HIC1 gene which is also conserved in the mouse and rat loci. Transcripts driven by this P2 promoter can be detected, albeit only through highly sensitive RT-PCR analyses. Thus, this low expression level has precluded the definition of the transcription initiation sites by primer extension and RNase protection assays. However, these P2-derived transcripts are expressed in mouse and human ovaries which argues, despite their low abundance, for a significant biological role.
The new exon 1c associated with the P2 promoter corresponds, in human and rat, to a new 5 0 untranslated region (5 0 -UTR). This 5 0 -UTR is rather long, ca. 1120 bp, as compared to the 100-300 bp 5 0 -UTR region Figure 4 Identification by RT-PCR analyses of the HIC1 1c 5 0 end in human tissues and breast epithelial cell lines. Primer sets located in two different exons were used to amplify by PCR the 1c-specific 5 0 end. The 650 bp of b-actin was amplified by b-actin-specific primers as internal control for the quality of the cDNAs. For the Marathon ready cDNAs (Clontech), PCR reactions were performed in presence ( þ cDNA, lanes 2 and 8) or in absence (À cDNA, lanes 3 and 9) of cDNA templates. Similarly, for the mammary glands epithelial cells, the PCR were conducted on a classical reaction mix containing RNAs and reverse transcriptase ( þ RT, lanes 4 and 6) and on a mix containing the same amount of RNAs but without reverse transcriptase to detect any amplification of contaminating genomic DNAs (À RT, lanes 5 and 7). Lane 1 shows a 100-bp ladder used as marker. The expected PCR products are indicated by close arrows. The open arrows indicate other alternative splicing products specific for each breast epithelial cell line Positions numbers for the invariant gt or ag dinucleotides are as in the human HIC1 genomic sequence (L41919). b Positions numbers for the invariant gt or ag dinucleotides are as in the 1631 bp human HIC1 genomic fragment (AJ404688) int refers to the two different 'internal' splicing events in the 1c exon specific of each BREPI cell line and giving rise, respectively, to the 1d and 1e exons A second G-C-rich promoter in the HIC1 gene S Pinte et al found in the majority of vertebrates mRNAs and compatible with the ribosome-scanning mechanism (Kozak, 1991) . These long 5 0 -UTRs are structured and generally well-conserved between the mouse and human genes, which suggest that they play an important role in the regulation of gene expression (Han et al., 2003) . However, in the case of HIC1, the long 5 0 -UTR is poorly conserved between human, mouse and rat except for the sequence corresponding to the noncoding exon 1a which is included in its 3 0 end. Thus, this 1c 5 0 -UTR also contains the P1 G-C-rich promoter and upstream sequences driving the transcription of the 1a type of transcripts. The presence of cryptic promoters in the long 5 0 -UTR of several genes has been recently put forward as an alternative hypothesis to the internal ribosome entry site (IRES)-mediated initiation mechanism for the efficient translation of genes with long 5 0 -UTR (Han et al., 2003) . However, the 1a transcripts contain a short 5 0 -UTR sequence (ca. 130 nucleotides) and represent by far the most abundant transcripts of the murine and human HIC1 loci (Gue´rardel et al., 2001; Chen et al., 2003) .
Taken together, all these results suggest that the transcripts derived from this conserved promoter would only modestly contribute to the total amount of HIC1 transcripts, unless in some yet unidentified cell types and/or developmental stages. Nevertheless, its conservation in three different mammalian species is a strong argument in favor of its functional importance. A plausible hypothesis would be that this conserved region, including the promoter and the upstream sequences, plays a role in the epigenetic regulation of HIC1. Indeed, this conserved region is embedded in a long CpG island (from positions 48 to 841 in the human AJ404688 sequence) using the EMBOSS program (http://www.ebi.ac.uk/emboss/cpgplot) in addition to the region encompassing the P1 promoter and 1a exon. Bisulfite genomic sequencing of human tumor cell lines not expressing HIC1 have detected in most cases a dense methylation only of the 1b promoter although the most abundant HIC1 transcripts in the corresponding normal tissues are derived from the 1a promoter (Gue´rardel et al., 2001) . The Hic1 þ /À heterozygous mice develop, late in their life a complex gender-dependant spectrum of malignant tumors with a predominance of carcinomas in males and lymphomas and sarcomas in females . A dense methylation of the 1a but not the 1b promoter on the remaining allele is observed in the lymphomas and sarcomas and conversely a dense methylation of the 1b promoter in the carcinomas and adenomas . Finally, the downstream 1b promoter is also methylated on approximately half of the alleles in some normal tissues (Fujii et al., 1998) . The mechanisms underlying this complex tissue-, age-and sex-dependant epigenetic regulation of HIC1 are yet to be identified. However, two recurrent themes are emerging. First, dense methylation of the 1b promoter appears sufficient to inhibit the expression of HIC1 even from the unmethylated major 1a promoter . Second, the upstream 1a promoter is protected from methylation in all normal tissues and in most human and murine tumors, a notable exception being the lymphomas and sarcomas observed in females Hic1 þ /À mice. Thus, this more upstream promoter 1c, which is active in many cell types and is embedded in a CpG island containing numerous Sp1 sites could protect the 1a promoter from de novo methylation (Feltus et al., 2003) and/or spreading of methylation related to cancer and aging (Yuasa, 2002) .
In addition to this complex and still poorly understood epigenetic regulation in normal and transformed 0 ends are generated by three different promoters. The various alternative exons 1 as well as the two splice variants are schematically shown below the human HIC1 genomic locus. In human, only the 1b exon contains an ATG codon in-frame with the ATG initiation codon located in exon 2 cells , our work has highlighted the existence of a complex transcriptional regulation of the HIC1 gene relying on three different promoters and alternative splicing mechanisms. Further analyses will be required to decipher the molecular bases of HIC1 transcription control, especially in the epithelial lineage which is a major target for human tumorigenesis.
Materials and methods

Cell culture
RK13, a rabbit kidney epithelial cell line, was maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. BREPI 73105 and 270898 are two primary cultures of epithelial cells derived from human mammary glands. These cells were cultured in a mixture of M199:MCDB105 (1 : 1) culture medium (Sigma, St Louis, MO, USA) supplemented with 10% fetal bovine serum, antibiotics and insulin (0.29 U/ml).
Construction of truncated promoter fusion plasmids
The pGL3-BB plasmid containing the human 1.58 kbp BamHI fragment encompassing most of the exon 1a as well as 5 0 flanking sequences has been described (Gue´rardel et al., 2001) . To subclone various portions of this genomic clone for promoter analyses, restriction fragments of 1.1 kbp (BamHISacI), 0.53 kbp (BamHI-ScaI), 0.34 kbp (KpnI-ScaI), 0.2 kbp (BamHI-KpnI) and 0.57 kbp (ScaI-SacI) were cloned into the appropriate sites in the pGL3-Basic polylinker (BglII for BamHI, KpnI, SmaI for ScaI and SacI) to yield, respectively, pGL3-BSa, pGL3-BSc, pGL3-KSc, pGL3-BK and pGL3-ScSa. All these clones have been verified by restriction mapping and sequencing.
Transient transfection and luciferase assays RK13 cells were plated at 50-60% confluence in 12-well plates the day before transfection. For transfection, cells were incubated with 475 ng of pGL3-Basic or its derivatives and 2 ml of PEI (Euromedex) for 6 h in 0.5 ml of OptiMEM and then in fresh complete medium as previously described (Gue´rardel et al., 2001) . The pSG5-bGal vector (25 ng) was cotransfected in each assay to correct for variations in transfection efficiency. Cells were rinsed in PBS 48 h after transfection, lysed and luciferase and bGal activities were measured as previously described (Gue´rardel et al., 2001) . Results presented are the means of at least three transfections.
Characterization of the new 5 0 untranslated region by RT-PCR analyses
The new alternative HIC1 end, 1c, was cloned by RT-PCR using the Marathon Ready cDNA Amplification Kit (Clontech, Palo Alto, USA) with a HIC1 gene-specific sense primer located just downstream of the newly identified putative G-C boxes in the human AJ404688 sequence (OF-HuHICc1) and an antisense primer located in the HIC1 BTB/POZ domain encoded as the rest of the protein by exon 2 (OR-HuHIC21), see Table 1 . After a first cycle of denaturation (951C, 6 min), PCR were carried out with AmpliTaq Gold (PERKIN ELMER) for 40 cycles (951C 1 min, 551C 1 min, 721C 1 min) with a final extension at 721C for 8 min. Each set of reactions always included a 'no cDNA' sample as negative control. Products of this PCR were cloned using the TOPO TA Cloning Kit (Invitrogen, Leek, The Netherlands) and sequenced.
Total RNAs (3 mg) obtained from the BREPI epithelial cells were reverse transcribed into single-stranded cDNAs using the SuperscriptII Reverse Transcriptase/RNase H kit (Life Technologies, Gibco BRL) and oligo dT as primer. These cDNAs were then used as templates in 40 cycles of PCR with the sense OF-HuHICc1 and antisense OR-HuHIC21 primers (see Table 1 ). These first PCR amplifications (1 ml) were subjected to a second PCR amplification with the nested primers OFHUHICc2 and OR-HuHIC22, respectively (Table 1) for another 40 cycles. The products of these second PCR were cloned and sequenced. In addition to a 'no sample' control, we performed an additional control with RNAs (the same mix but incubated without reverse transcriptase) instead of cDNAs to rule out contamination by genomic DNA. Similarly, doublestranded cDNAs were prepared from normal adult mice ovaries polyA þ RNAs using the cDNA Cloning kit (Stratagene) and size-selected by centrifugation on sucrose gradients. Fraction 6 (5-10 kbp) was amplified by two rounds of PCR with specific nested oligonucleotides (Table 1) .
